From: A decade of intestinal protozoan epidemiology among settled immigrants in Qatar
Prevalence (95 % confidence limits) | ||||
---|---|---|---|---|
Period 1 | Period 2 | Period 3 | Combined *** | |
2005–2008 | 2009–2011 | 2012–2014 | ||
Protozoa* | ||||
Blastocystis hominis | 4.32 (3.907–4.738) | 2.78 (2.439–3.124) | 3.26 (2.930–3.586) | 3.45 (3.240–3.658) |
Giardia duodenalis | 1.94 (1.662–2.226) | 1.44 (1.188–1.684) | 1.10 (0.911–1.297) | 1.47 (1.331–1.606) |
Chilomastix mesnili | Nd | 0.05 (0.012–0.116) | 0.03 (0.006–0.078) | 0.03 (0.014–0.072) |
Entamoeba coli | Nd | 0.50 (0.361–0.668) | 0.45 (0.338–0.597) | 0.47 (0.383–0.578) |
Entamoeba hartmanni | Nd | 0.03 (0.007–0.099) | 0.02 (0.002–0.064) | 0.02 (0.008–0.058) |
Endolimax nana | Nd | 0.88 (0.697–1.101) | 0.53 (0.400–0.677) | 0.68 (0.568–0.796) |
Iodamoeba buetschlii | Nd | 0.15 (0.078–0.251) | 0.13 (0.075–0.220) | 0.14 (0.093–0.202) |
All Non pathogenic amoebae** | 2.52 (2.199–2.840) | 1.38 (1.136–1.623) | 0.95 (0.773–1.132) | 1.57 (1.432–1.717) |
Entamoeba histolytica/dispar** | 0.29 (0.193–0.427) | 0.23 (0.138–0.349) | 0.12 (0.068–0.209) | 0.21 (0.159–0.268) |
Cryptosporidium sp. | Nd | 0.05 (0.012–0.116) | 0.06 (0.025–0.128) | 0.05 (0.027–0.098) |
All protozoa combined | 7.98 (7.429–8.536) | 5.13 (4.673–5.593) | 4.89 (4.488–5.286) | 5.93 (5.664–6.205) |